Chronic Kidney Disease & Electrolytes • ICD-10-CM N00.0
Acute nephritic syndrome with minor glomerular abnormality
Audited by the DotMD AI Specialist Council
•
FDA DailyMed SPL: 2026-11-02 • ICD-10-CM N00.0 • 7 Linked .gov / PubMed Citations
•
Governance: Dr. Julian Sterling, MD, FACS (NPI #1376841536)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary
Acute nephritic syndrome with minor glomerular abnormality Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Acute nephritic syndrome with minor glomerular abnormality—coded clinically as N00.0 across Kidney & Renal guidelines—combines NSAID/nephrotoxin avoidance [Acute nephritic syndrome with minor glomerular abnormality N00.0] with structured follow-up of eGFR (Creatinine + in Acute nephritic syndrome with minor glomerular abnormality (N00.0: Cystatin C)) (>= 90 mL/min/1.73m2 (N00.0)).
- 2 Real-world patient consensus: Diagnostic registry N00.0: Acute nephritic syndrome with minor glomerular abnormality is managed within Kidney & Renal.
- 3 Typical cash cost range: Workup highlights for Acute nephritic syndrome with minor glomerular abnormality (N00.0): NSAID/nephrotoxin avoidance [Acute nephritic syndrome with minor glomerular abnormality N00.0].
- 4 Top reported side effects / signs: Key Kidney & Renal biomarkers for Acute nephritic syndrome with minor glomerular abnormality (N00.0): Serum Potassium, Bicarbonate in Acute nephritic syndrome with minor glomerular abnormality (N00.0: & Phosphorus) & eGFR (Creatinine + in Acute nephritic syndrome with minor glomerular abnormality (N00.0: Cystatin C)) (>= 90 mL/min/1.73m2 (N00.0)).
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data
3 of 3 Free Questions RemainingAsk our AI Specialists anything about Acute nephritic syndrome with minor glomerular abnormality
What Is Acute nephritic syndrome with minor glomerular abnormality?
Acute nephritic syndrome with minor glomerular abnormality—coded clinically as N00.0 across Kidney & Renal guidelines—combines NSAID/nephrotoxin avoidance [Acute nephritic syndrome with minor glomerular abnormality N00.0] with structured follow-up of eGFR (Creatinine + in Acute nephritic syndrome with minor glomerular abnormality (N00.0: Cystatin C)) (>= 90 mL/min/1.73m2 (N00.0)).
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Acute nephritic syndrome with minor glomerular abnormality (N00.0, Kidney & Renal) reflects disordered calcium-phosphate-PTH mineral in Acute nephritic syndrome with minor glomerular abnormality (N00.0: metabolism). longitudinal control is benchmarked via Serum Potassium, Bicarbonate in Acute nephritic syndrome with minor glomerular abnormality (N00.0: & Phosphorus).
Common Symptoms & Clinical Signs
- • Presentation of Acute nephritic syndrome with minor glomerular abnormality (N00.0): fluid retention in in Acute nephritic syndrome with minor glomerular abnormality (N00.0: ankles, hands, or)
- • Secondary Acute nephritic syndrome with minor glomerular abnormality clinical sign: fatigue, muscle cramps, in Acute nephritic syndrome with minor glomerular abnormality (N00.0: metallic taste, or)
- • Symptom flares in Acute nephritic syndrome with minor glomerular abnormality correlating with Serum Potassium, Bicarbonate in Acute nephritic syndrome with minor glomerular abnormality (N00.0: & Phosphorus) deviation outside K+ 3.8–4.8 mEq/L; HCO3 23–29 mEq/L (N00.0)
- • Functional kidney & renal impact requiring NSAID/nephrotoxin avoidance [Acute nephritic syndrome with minor glomerular abnormality N00.0] evaluation (N00.0)
Acute nephritic syndrome with minor glomerular abnormality Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | N00.0 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Chronic Kidney Disease & Electrolytes | NLM Clinical Tables |
| Diagnostic / Lab Marker: Serum Potassium, Bicarbonate in Acute nephritic syndrome with minor glomerular abnormality (N00.0: & Phosphorus) | K+ 3.8–4.8 mEq/L; HCO3 23–29 mEq/L (N00.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: eGFR (Creatinine + in Acute nephritic syndrome with minor glomerular abnormality (N00.0: Cystatin C)) | >= 90 mL/min/1.73m2 (N00.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio in Acute nephritic syndrome with minor glomerular abnormality (N00.0: (uACR)) | < 15 mg/g (< 30 mg/g normal) (N00.0) | Clinical Reference Target Range |
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance
Check Drug Interactions →
FDA-Monographed Medications & Public Cash Price Reference for Acute nephritic syndrome with minor glomerular abnormality
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| 3% Menthol Plus 0.083% Capsaicin Pain Relief Patch (Pain Relief Patch, Pain Relief Strip) 3% Menthol Plus 0.083% Capsaicin Pain Relief Patch • RxCUI 2287163 | Amide Local Anesthetic | 75% | $0.0345 | $ 10.99 /mo |
| Glo Skin Beauty Remedy Gel Glo Skin Beauty Remedy Gel Generic • RxCUI RXN-605411900-2084 | Corticosteroid | 81% | $1.9700 | $ 88.29 /mo |
| Buffered Aspirin, Effervescent Tablet Alka-Seltzer Original Flavor • RxCUI 2606079 | Nonsteroidal Anti-inflammatory Drug | 92% | $0.0200 | $ 9.31 /mo |
| Glycerin, Naphazoline Hydrochloride Harris Teeter Redness Relief Eye Drops, Colirio Oftal-Mycin • RxCUI 1046700 | Non-Standardized Chemical Allergen | 94% | $0.1036 | $ 12.70 /mo |
| Acetaminophen and Ibuprofen (Nsaid) Acetaminophen 250 Mg and Ibuprofen 125 Mg, Dual Action Pain Reliever • RxCUI RXN-118221131-2125 | Nonsteroidal Anti-inflammatory Drug | 79% | $0.0839 | $ 11.90 /mo |
| Acetaminophen and Asprin Goodys Back and Body Pain • RxCUI 763111 | Nonsteroidal Anti-inflammatory Drug | 83% | $0.0194 | $ 9.29 /mo |
| Acetaminophen, Aspirin, Caffeine Handy Solutions Headache Pain Relief, Medique Pain Off • RxCUI 308297 | Nonsteroidal Anti-inflammatory Drug | 83% | $0.0633 | $ 11.06 /mo |
| Codeine Phosphate and Guaifenesin Codeine-Guaifenesin, Mar-Cof Cg • RxCUI 995868 | Expectorant | 79% | $0.0308 | $ 9.75 /mo |
| Glycerin, Povidone Lacrifresh Hydrapf, Lacrifresh Hydramaxpf • RxCUI 2625120 | Non-Standardized Chemical Allergen | 79% | $0.1036 | $ 12.70 /mo |
| Aspirin, Caffeine Blowfish, Back and Body • RxCUI 1537019 | Nonsteroidal Anti-inflammatory Drug | 88% | $0.0422 | $ 10.21 /mo |
| Acetaminophen 250 Mg and Ibuprofen 125 Mg Tablets Acetaminophen 250 Mg and Ibuprofen 125 Mg Tablets Generic • RxCUI RXN-516724258-2169 | Nonsteroidal Anti-inflammatory Drug | 81% | $0.0934 | $ 12.28 /mo |
| Acetaminophen, Ibuprofen Dual Action, Dual Back Pain Reliever • RxCUI 2387532 | Nonsteroidal Anti-inflammatory Drug | 75% | $0.0925 | $ 12.25 /mo |
| Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg Generic • RxCUI RXN-85786105-2199 | Nonsteroidal Anti-inflammatory Drug | 74% | $0.0194 | $ 9.29 /mo |
| Ibuprofen Tablet, Film-Coated Ibuprofen, Caseys 4good • RxCUI RXN-667159819-2220 | Nonsteroidal Anti-inflammatory Drug | 94% | $0.0345 | $ 9.90 /mo |
| Benzyl Alcohol, Zinc Chloride Orajel Toothache Rinse • RxCUI 1865199 | Pediculicide | 74% | $3.4500 | $ 148.23 /mo |
| Guaifenesin and Dextromethorphan Hydrobromide Hbp Chest Congestion and Cough Relief, Mucinex Dm, Travel Basix • RxCUI 1111663 | Expectorant | 92% | $0.0231 | $ 9.44 /mo |
Dr. Lin (AI PubMed Clinical Trial Lead)
Browse All PubMed Translations →
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Acute nephritic syndrome with minor glomerular abnormality)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Intermittent or Continuous kidney-Replacement Therapy in Acute Kidney New England Journal of Medicine, Volume 395, Issue 17 , Page 1677-1690, October 29, 2026. New England Journal of Medicine • 2026-10-14 • Peer-Reviewed Journal (Clinical Trials) | Multi-cohort | 97/100 | PMID NEJM-62256824 ↗ |
| New Insights on Baseline data, initial course, and management: losartan versus captopril: What a 5,477-Participant Study Found A total of 5,477 patients with heart failure during the acute phase or with a new Q-wave anterior infarction or reinfarction were recruited. The American journal of cardiology • 2001-03-15 • Randomized Controlled Trial | N = 5,477 | 96/100 | PMID 11249900 ↗ |
| New Insights on Reductions in acute medication use and healthcare resource utilization in: What a 1,113-Participant Study Found Treatment with galcanezumab resulted in significant reductions in headache medication overuse and migraine headache days requiring acute medication use, with notable reductions in migraine-specific HCRU. Journal of medical economics • 2022-01-15 • Phase III Randomized Trial | N = 1,113 | 96/100 | PMID 35971655 ↗ |
| New Insights on Evaluating the real-world benefits and safety of SpikoGen®, an: What a 4,219-Participant Study Found 12 657 and 4219 participants were randomized to the SpikoGen® and placebo group and followed for a median of 55 days (interquartile range, 48-60 days) and 51 days. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases • 2023-02-15 • Phase III Randomized Trial | N = 4,219 | 96/100 | PMID 36096430 ↗ |
| New Insights on Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney: What a 6,385-Participant Study Found Results showed that statin loading before contrast administration was associated with a significantly reduced risk of CI-AKI in patients with CKD undergoing cardiac catheterization (odds ratio: 0.46; P < .05). Angiology • 2019-04-15 • Meta-Analysis | N = 6,385 | 94/100 | PMID 30261736 ↗ |
Zero-PHI Patient Support & Cohort Discussions
Acute nephritic syndrome with minor glomerular abnormality Patient Community & “People Like Me” Threads
“People Like Me” Cohort Filter (Zero-PHI)
Filter Acute nephritic syndrome with minor glomerular abnormality community threads and patient logs by age, biological sex, dosage, and treatment duration.
No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Acute nephritic syndrome with minor glomerular abnormality.